Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Grant/Award of 12,100 AKTX shares, $95.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Akari Therapeutics Plc (AKTX) | Grant/Award | 12,100 | $95.6K |
| Oct 2, 2026 | AtlasClear Holdings, Inc. (ATCH) | Grant/Award | 777,332 | n/a |
| Sep 28, 2026 | AtlasClear Holdings, Inc. (ATCH) | Purchase | 50,000 | $10.9K |
| Jul 17, 2026 | AtlasClear Holdings, Inc. (ATCH) | Grant/Award | 45,000 | n/a |
| Dec 19, 2025 | Akari Therapeutics Plc (AKTX) | Purchase | 247,462 | n/a |
| Apr 29, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 44,642 | $50.0K |
| Mar 24, 2025 | Akari Therapeutics Plc (AKTX) | Grant/Award | 175,000 | n/a |
| Apr 16, 2024 | AtlasClear Holdings, Inc. (ATCH) | Other (see footnotes) | 201,860 | n/a |